Selected Drugs Clear All
MultiCheck Results
- 0
Interaction
Additional Considerations |
||
|
teclistamab
in Tecvayli (teclistamab-cqyv)
|
||
|
caution advised with narrow therapeutic index drugs, especially during teclistamab initiation/titration and up to 7 days after first full tx dose or during/after CRS; teclistamab may incr. cytokine release leading to suppression of metabolic enzymes, causing incr. drug levels, risk of adverse effects |
||